# Biogen

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/biogen/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | American multinational biotechnology company |
| OpenAlex ID | https://openalex.org/F4320308604 |
| ROR ID | https://ror.org/02jqkb192 |
| Works | 17,839 |

## Funder papers

- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis](https://scholariq.org/papers/executive-summary-of-the-kdigo-2024-clinical-practice-guideline-for-the-2/)
- [Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany](https://scholariq.org/papers/costs-of-illness-in-amyotrophic-lateral-sclerosis-als-a-cross-sectional-survey/)
- [Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial](https://scholariq.org/papers/spironolactone-versus-placebo-in-patients-undergoing-maintenance-dialysis/)
- [Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial](https://scholariq.org/papers/virtual-house-calls-for-parkinson-disease-connect-parkinson-study-protocol-for-a/)
- [Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months](https://scholariq.org/papers/impact-of-nusinersen-on-the-health-related-quality-of-life-and-caregiver-burden/)
- [Caregiver Burden and Quality of Life Across Alzheimer’s Disease Severity Stages](https://scholariq.org/papers/caregiver-burden-and-quality-of-life-across-alzheimer-s-disease-severity-stages/)
- [Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial](https://scholariq.org/papers/impact-of-oral-semaglutide-on-kidney-outcomes-in-people-with-type-2-diabetes/)
- [Epidemiology, disease evolution and economic burden of amyotrophic lateral sclerosis in France using the French national health data system](https://scholariq.org/papers/epidemiology-disease-evolution-and-economic-burden-of-amyotrophic-lateral/)
- [Quantitative Analysis of Instrument Motion Paths in Cataract Surgery across a Resident’s Training](https://scholariq.org/papers/quantitative-analysis-of-instrument-motion-paths-in-cataract-surgery-across-a/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.